Tradestie Institutional Equity Comparison Engine

SGHT vs PMI โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PMI Overall Edge

PMI Captures Institutional Edge (3โ€“1 Pillars ยท 5โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Picard Medical, Inc. (PMI) driven by superior Valuation, Growth & Margin, Momentum & Technical while SGHT counters with relative strength in Options & Structure. Fundamentally, SGHT trades at N/M Forward P/E with -20.2% operating margin (+25.2% YoY revenue) versus PMI at N/M Forward P/E and -248.1% operating margin (+38.6% YoY). In options structure, SGHT sits in BREAKOUT (8th %ile IV; Dealer Gamma Walls on Pro) against PMI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner PMI
SGHT N/M vs PMI N/M Fwd P/E
Growth & Margin Winner PMI
Op Margin -20.2% vs -248.1% ยท YoY +25.2% vs +38.6%
Momentum & Technical Winner PMI
1Y +48.7% vs +107.2% ยท 52W Pos 88% vs 34%
Options & Structure Winner SGHT
BREAKOUT (8th %ile IV) vs UNCLASSIFIED (N/A IV)
SGHT NASDAQ
Sight Sciences, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$10.62
-1.39% 1D
Market Cap $598.6M
1M Return +22.07%
1Y Return +48.74%
Forward P/E N/M
Unified AI Score
34.0 / 100 SELL
Tech 50.0 Fund 39.0 Flow 70.0 Mom 50.0
PMI NYSE American
Picard Medical, Inc.
Surgical & Medical Instruments & Apparatus
$6.30
-2.17% 1D
Market Cap $17.1M
1M Return -34.58%
1Y Return +107.24%
Forward P/E N/M
Unified AI Score
48.4 / 100 HOLD
Tech 39.0 Fund 45.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SGHT +48.74% PMI +107.24% Spread: +99.29 pp (PMI Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period SGHT Revenue PMI Revenue SGHT Op. Margin PMI Op. Margin Margin Edge
FY2020 $30M N/A -116.5% N/A SGHT
FY2021 $50M N/A -105.2% N/A SGHT
FY2022 $70M N/A -117.7% N/A SGHT
FY2023 $80M N/A -70.7% N/A SGHT
FY2024 $80M $0M -63.3% -312.3% SGHT
FY2025 $80M $0M -48.0% -268.4% SGHT

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SGHT (4) vs PMI (5)
Institutional Metric SGHT PMI Criterion Row Winner
Market Capitalization Scale $598.6M $17.1M Larger Scale SGHT
Trailing P/E Ratio Valuation N/M 2.9x Lower Multiple PMI
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +25.2% +38.6% Higher Growth PMI
Operating Margin (TTM) Profitability -20.2% -248.1% Higher Margin SGHT
Net Profit Margin Profitability -32.1% 0.0% Higher Margin PMI
Return on Equity (ROE) Capital Efficiency -50.1% 0.0% Higher ROE PMI
52-Week Range Position Momentum 88% ($3โ€“$12) 34% ($0โ€“$18) Stronger Trend SGHT
Beta / 30D Volatility Risk Regime 1.06ฮฒ ยท 46% Vol 54.06ฮฒ ยท 134% Vol Lower Realized Risk SGHT
Unified Institutional Score Composite Signal 34.0 / 100 (SELL) 48.4 / 100 (HOLD) Higher Composite PMI

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SGHT vs PMI Buy Guide
SGHT BREAKOUT
36d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 8th %ile
IV Regime Compressed (<25th %ile)
Live SGHT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PMI UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live PMI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SGHT nor PMI registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.